Stratasys Releases Third Quarter 2024 Financial Results
Raises 2024 Margins and Profitability Outlook
-
Revenue of
$140.0 million , compared to$162.1 million in third quarter 2023 - Eighth consecutive quarter of year-over-year growth in recurring consumables revenue reflects continued strong printer utilization
- Improved GAAP gross margin by 430bps to 44.8% and non-GAAP gross margin by 130bps to 49.6% compared to third quarter 2023
-
GAAP net loss of
$26.6 million , or$0.37 per diluted share; non-GAAP net income resumes achieving profitability with$0.4 million , or$0.01 per diluted share -
$4.5 million of cash used in operations; year-to-date operating cash flow remains positive -
Adjusted EBITDA of
$5.1 million - Restructuring cost savings being delivered ahead of plan
- Raises outlook for full-year 2024 margins and profitability metrics
Third Quarter 2024 Financial Results Compared to Third Quarter 2023:
-
Revenue of
$140.0 million , compared to$162.1 million , reflects ongoing impacts from current macroeconomic environment on customer capital equipment spending. - GAAP gross margin of 44.8%, compared to 40.5% and non-GAAP gross margin of 49.6%, compared to 48.3%.
-
GAAP operating loss of
$25.5 million , compared to an operating loss of$42.8 million . -
Non-GAAP operating loss of
$0.1 million , compared to non-GAAP operating income of$4.1 million . -
GAAP net loss of
$26.6 million , or$0.37 per diluted share, compared to a net loss of$47.3 million , or$0.68 per diluted share. -
Non-GAAP net income of
$0.4 million , or$0.01 per diluted share, compared to non-GAAP net income of$2.4 million , or$0.04 per diluted share. -
Adjusted EBITDA of
$5.1 million , compared to$9.8 million . -
Cash used in operating activities of
$4.5 million , compared to$12.7 million .
Dr.
2024 Financial Outlook:
Based on current market conditions and assuming that the impacts of global inflationary pressures, relatively high interest rates and supply chain costs do not impede economic activity further, the Company is maintaining its revenue outlook and raising its margins and profitability outlook for 2024 as follows:
-
Revenue of
$570 million to$580 million . - Non-GAAP gross margins between 49.0% to 49.2%.
-
Operating expenses in the range of
$276 million to$278 million . - Non-GAAP operating margins to range between 0.6% to 1.3%.
-
GAAP net loss of
$105 million to$90 million , or ($1.48 ) to ($1.27 ) per diluted share.- Includes one-time extraordinary costs associated with Stratasys’ strategic alternatives process.
-
Non-GAAP net income of
$2.1 to$5.0 million , or$0.03 to$0.07 . -
Adjusted EBITDA of
$25 million to$28 million . -
Capital expenditures of
$15 million to$20 million .
Non-GAAP earnings guidance excludes
Appropriate reconciliations between GAAP and non-GAAP financial measures are provided in a table at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures.
The Company plans to webcast its conference call to discuss its third quarter 2024 financial results on
The investor conference call will be available via live webcast on the Stratasys Web site at investors.stratasys.com, or directly at the following web address:
https://event.choruscall.com/mediaframe/webcast.html?webcastid=xEC56y1o
To participate by telephone, the
To learn more about
Cautionary Statement Regarding Forward-Looking Statements
The statements in this press release regarding
Use of Non-GAAP Financial Measures
The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions, divestments and strategic process-related expense or gains and reorganization-related charges or gains, and legal provisions and (ii) excluding non-cash items such as share-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity-method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a view of our performance that is comparable to those of other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.
|
||||||||
Consolidated Balance Sheets | ||||||||
(in thousands, except share data) | ||||||||
|
|
|||||||
ASSETS | ||||||||
Current assets | ||||||||
Cash and cash equivalents |
$ |
63,956 |
|
$ |
82,585 |
|
||
Short-term bank deposits |
|
80,000 |
|
|
80,000 |
|
||
Accounts receivable, net of allowance for credit losses of |
|
153,653 |
|
|
172,009 |
|
||
Inventories |
|
195,188 |
|
|
192,976 |
|
||
Prepaid expenses |
|
8,522 |
|
|
7,929 |
|
||
Other current assets |
|
18,025 |
|
|
24,596 |
|
||
Total current assets |
|
519,344 |
|
|
560,095 |
|
||
Non-current assets | ||||||||
Property, plant and equipment, net |
|
183,969 |
|
|
197,552 |
|
||
|
|
100,086 |
|
|
100,051 |
|
||
Other intangible assets, net |
|
111,883 |
|
|
127,781 |
|
||
Operating lease right-of-use assets |
|
32,591 |
|
|
18,895 |
|
||
Long-term investments |
|
120,070 |
|
|
115,083 |
|
||
Other non-current assets |
|
14,734 |
|
|
14,448 |
|
||
Total non-current assets |
|
563,333 |
|
|
573,810 |
|
||
Total assets |
$ |
1,082,677 |
|
$ |
1,133,905 |
|
||
LIABILITIES AND EQUITY | ||||||||
Current liabilities | ||||||||
Accounts payable |
$ |
48,157 |
|
$ |
46,785 |
|
||
Accrued expenses and other current liabilities |
|
35,328 |
|
|
36,656 |
|
||
Accrued compensation and related benefits |
|
29,428 |
|
|
33,877 |
|
||
Deferred revenues - short-term |
|
49,788 |
|
|
52,610 |
|
||
Operating lease liabilities - short-term |
|
6,714 |
|
|
6,498 |
|
||
Total current liabilities |
|
169,415 |
|
|
176,426 |
|
||
Non-current liabilities | ||||||||
Deferred revenues - long-term |
|
19,109 |
|
|
23,655 |
|
||
Deferred income taxes - long-term |
|
574 |
|
|
723 |
|
||
Operating lease liabilities - long-term |
|
25,420 |
|
|
12,162 |
|
||
Contingent consideration - long-term |
|
12,410 |
|
|
11,900 |
|
||
Other non-current liabilities |
|
23,971 |
|
|
24,200 |
|
||
Total non-current liabilities |
|
81,484 |
|
|
72,640 |
|
||
Total liabilities |
$ |
250,899 |
|
$ |
249,066 |
|
||
Contingencies (see note 12) | ||||||||
Equity | ||||||||
Ordinary shares, |
$ |
200 |
|
$ |
195 |
|
||
Additional paid-in capital |
|
3,117,626 |
|
|
3,091,649 |
|
||
Accumulated other comprehensive loss |
|
(7,782 |
) |
|
(7,079 |
) |
||
Accumulated deficit |
|
(2,278,266 |
) |
|
(2,199,926 |
) |
||
Total equity |
|
831,778 |
|
|
884,839 |
|
||
Total liabilities and equity |
$ |
1,082,677 |
|
$ |
1,133,905 |
|
|
|||||||||||||||||
Consolidated Statements of Operations | |||||||||||||||||
(in thousands, except per share data) |
Three Months Ended |
Nine Months Ended |
|||||||||||||||
|
2024 |
|
|
|
2023 |
|
|
|
2024 |
|
|
|
2023 |
|
|||
unaudited | unaudited | unaudited | unaudited | ||||||||||||||
Revenues | |||||||||||||||||
Products |
$ |
94,092 |
|
$ |
113,270 |
|
$ |
286,882 |
|
$ |
323,353 |
|
|||||
Services |
|
45,916 |
|
|
48,863 |
|
|
135,217 |
|
|
147,908 |
|
|||||
|
140,008 |
|
|
162,133 |
|
|
422,099 |
|
|
471,261 |
|
||||||
Cost of revenues | |||||||||||||||||
Products |
|
47,707 |
|
|
59,546 |
|
|
144,220 |
|
|
168,235 |
|
|||||
Services |
|
29,571 |
|
|
36,938 |
|
|
90,752 |
|
|
105,760 |
|
|||||
|
77,278 |
|
|
96,484 |
|
|
234,972 |
|
|
273,995 |
|
||||||
Gross profit |
|
62,730 |
|
|
65,649 |
|
|
187,127 |
|
|
197,266 |
|
|||||
Operating expenses | |||||||||||||||||
Research and development, net |
|
24,700 |
|
|
23,567 |
|
|
74,357 |
|
|
69,347 |
|
|||||
Selling, general and administrative |
|
63,495 |
|
|
84,880 |
|
|
188,731 |
|
|
221,173 |
|
|||||
|
88,195 |
|
|
108,447 |
|
|
263,088 |
|
|
290,520 |
|
||||||
Operating loss |
|
(25,465 |
) |
|
(42,798 |
) |
|
(75,961 |
) |
|
(93,254 |
) |
|||||
Financial income, net |
|
1,009 |
|
|
687 |
|
|
1,500 |
|
|
2,147 |
|
|||||
Loss before income taxes |
|
(24,456 |
) |
|
(42,111 |
) |
|
(74,461 |
) |
|
(91,107 |
) |
|||||
Income tax expenses |
|
842 |
|
|
645 |
|
|
2,320 |
|
|
5,145 |
|
|||||
Share in losses of associated companies |
|
1,316 |
|
|
4,523 |
|
|
1,559 |
|
|
11,866 |
|
|||||
Net loss |
$ |
(26,614 |
) |
$ |
(47,279 |
) |
$ |
(78,340 |
) |
$ |
(108,118 |
) |
|||||
Net loss per share - basic and diluted | |||||||||||||||||
Basic |
$ |
(0.37 |
) |
$ |
(0.68 |
) |
$ |
(1.11 |
) |
$ |
(1.58 |
) |
|||||
Diluted |
$ |
(0.37 |
) |
$ |
(0.68 |
) |
$ |
(1.11 |
) |
$ |
(1.58 |
) |
|||||
Weighted average ordinary shares outstanding | |||||||||||||||||
Basic |
|
71,271 |
|
|
69,093 |
|
|
70,670 |
|
|
68,432 |
|
|||||
Diluted |
|
71,271 |
|
|
69,093 |
|
|
70,670 |
|
|
68,432 |
|
Three Months Ended |
||||||||||||||||
|
2024 |
|
Non-GAAP |
|
2024 |
|
|
2023 |
|
Non-GAAP |
2023 |
|||||
GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | |||||||||||
|
||||||||||||||||
Gross profit (1) |
$ |
62,730 |
|
$ |
6,768 |
$ |
69,498 |
|
$ |
65,649 |
|
$ |
12,617 |
$ |
78,266 |
|
Operating income (loss) (1,2) |
|
(25,465 |
) |
$ |
25,351 |
|
(114 |
) |
|
(42,798 |
) |
$ |
46,885 |
|
4,087 |
|
Net income (loss) (1,2,3) |
|
(26,614 |
) |
$ |
26,985 |
|
371 |
|
|
(47,279 |
) |
$ |
49,725 |
|
2,446 |
|
Net income (loss) per diluted share to |
$ |
(0.37 |
) |
$ |
0.38 |
$ |
0.01 |
|
$ |
(0.68 |
) |
$ |
0.72 |
$ |
0.04 |
|
(1) |
Acquired intangible assets amortization expense |
|
4,507 |
|
5,142 |
|||||||||||
Non-cash stock-based compensation expense |
|
912 |
|
891 |
||||||||||||
Restructuring and other related costs |
|
1,349 |
|
6,584 |
||||||||||||
|
6,768 |
|
12,617 |
|||||||||||||
(2) |
Acquired intangible assets amortization expense |
|
1,124 |
|
2,599 |
|||||||||||
Non-cash stock-based compensation expense |
|
5,657 |
|
6,588 |
||||||||||||
Restructuring and other related costs |
|
7,585 |
|
2,360 |
||||||||||||
Revaluation of investments |
|
— |
|
4,300 |
||||||||||||
Contingent consideration |
|
519 |
|
265 |
||||||||||||
Legal and other expenses |
|
3,698 |
|
18,156 |
||||||||||||
|
18,583 |
|
34,268 |
|||||||||||||
|
25,351 |
|
46,885 |
|||||||||||||
(3) |
Corresponding tax effect and other expenses |
|
294 |
|
153 |
|||||||||||
Equity method related expenses |
|
981 |
|
2,525 |
||||||||||||
Finance expenses |
|
359 |
|
162 |
||||||||||||
$ |
26,985 |
$ |
49,725 |
|||||||||||||
(4) |
Weighted average number of ordinary shares outstanding- Diluted |
|
71,271 |
|
|
71,417 |
|
|
69,093 |
|
|
69,815 |
Nine months ended |
||||||||||||||||
|
2024 |
|
Non-GAAP |
|
2024 |
|
|
2023 |
|
Non-GAAP |
2023 |
|||||
GAAP | Adjustments | Non-GAAP | GAAP | Adjustments | Non-GAAP | |||||||||||
|
||||||||||||||||
Gross profit (1) |
$ |
187,127 |
|
$ |
20,082 |
$ |
207,209 |
|
$ |
197,266 |
|
$ |
29,199 |
$ |
226,465 |
|
Operating income (loss) (1,2) |
|
(75,961 |
) |
$ |
71,450 |
|
(4,511 |
) |
|
(93,254 |
) |
$ |
103,866 |
|
10,612 |
|
Net income (loss) attributable to |
|
(78,340 |
) |
$ |
74,058 |
|
(4,282 |
) |
|
(108,118 |
) |
$ |
114,179 |
|
6,061 |
|
Net income (loss) per diluted share attributable to |
$ |
(1.11 |
) |
$ |
1.05 |
$ |
(0.06 |
) |
$ |
(1.58 |
) |
$ |
1.67 |
$ |
0.09 |
|
(1) |
Acquired intangible assets amortization expense |
|
14,080 |
|
14,157 |
|||||||||||
Non-cash stock-based compensation expense |
|
2,874 |
|
2,822 |
||||||||||||
Restructuring and other related costs |
|
3,128 |
|
12,220 |
||||||||||||
|
20,082 |
|
29,199 |
|||||||||||||
(2) |
Acquired intangible assets amortization expense |
$ |
4,694 |
$ |
7,479 |
|||||||||||
Non-cash stock-based compensation expense |
$ |
19,689 |
$ |
20,920 |
||||||||||||
Restructuring and other related costs |
$ |
12,144 |
$ |
6,626 |
||||||||||||
Revaluation of investments |
$ |
1,900 |
$ |
4,880 |
||||||||||||
Contingent consideration |
$ |
1,553 |
$ |
877 |
||||||||||||
Legal and other expenses |
$ |
11,388 |
$ |
33,885 |
||||||||||||
|
51,368 |
|
74,667 |
|||||||||||||
|
71,450 |
|
103,866 |
|||||||||||||
(3) |
Corresponding tax effect and other expenses |
$ |
732 |
$ |
3,404 |
|||||||||||
Equity method related expenses |
$ |
352 |
$ |
1,827 |
||||||||||||
Finance expenses |
$ |
1,524 |
$ |
5,081 |
||||||||||||
$ |
74,058 |
$ |
114,179 |
|||||||||||||
(4) |
Weighted average number of ordinary shares outstanding- Diluted |
|
70,670 |
|
|
70,670 |
|
|
68,432 |
|
|
69,046 |
Fiscal Year 2024 | ||
(in millions, except per share data) | ||
GAAP net loss | ( |
|
Adjustments | ||
Stock-based compensation expense |
|
|
Intangible assets amortization expense |
|
|
Reorganization and other |
|
|
Tax expense (benefit) related to Non-GAAP adjustments |
|
|
Non-GAAP net income |
|
|
GAAP loss per share | ( |
|
Non-GAAP diluted earnings per share |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20241113452010/en/
CCO & VP Investor Relations
Yonah.Lloyd@stratasys.com
Source: